The agency notes that state-licensed pharmacies that are not outsourcing facilities are not required to submit adverse events, so these are likely underreported
Different scales
In case of CKD, the use of a GLP-1RA with proven cardiovascular benefit is only recommended in those who have not achieved individualized glycemic targets despite SGLT2i treatment, or in whom SGLT2is are contraindicated or not tolerated [6, 8]
Rare adverse events that might emerge in large studies could remain invisible in community discussions
Patient-reported outcomes are superior in patients with type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study
lucidum , Pleurotus ostreatus , and Cordyceps militaris , have demonstrated the ability to modulate glycemic response ( -cells and Langerhans islets